DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Dextroamp Saccharate,amp Aspartate,dextroamp Sulfate And Amp Sulfate patents expire, and when can generic versions of Dextroamp Saccharate,amp Aspartate,dextroamp Sulfate And Amp Sulfate launch?
Dextroamp Saccharate,amp Aspartate,dextroamp Sulfate And Amp Sulfate is a drug marketed by Barr Labs Inc and is included in one NDA.
The generic ingredient in DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE is amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. There are fifty-five drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate profile page.
Summary for DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE at DailyMed |